Description
Pentasa (Mesalazine) Tablets 500 mg
Ingredients:
Each tablet contains 500 mg of mesalazine.
Dosage:
The usual adult dose is 2 to 4 tablets taken 4 times a day.
Indications:
Pentasa tablets are indicated for the treatment of mild to moderate ulcerative colitis and Crohn’s disease.
Contraindications:
Do not use Pentasa if you are allergic to mesalazine or any other ingredients in the tablets.
Directions:
Swallow the tablets whole with a glass of water. Do not crush or chew the tablets.
Scientific Evidence:
Mesalazine, the active ingredient in Pentasa tablets, is known for its efficacy in treating inflammatory bowel diseases. Studies have shown that mesalazine reduces inflammation in the colon, alleviating symptoms like diarrhea, abdominal pain, and rectal bleeding.
Clinical trials have demonstrated Pentasa’s effectiveness in maintaining remission in patients with ulcerative colitis and Crohn’s disease. The controlled release formulation ensures targeted delivery to inflamed bowel areas, enhancing therapeutic outcomes.
Additional Information:
- Storage: Store Pentasa tablets at room temperature away from moisture and heat.
- Side Effects: Common side effects may include headache, nausea, and abdominal pain.
- Pregnancy and Lactation: Seek medical advice before using Pentasa during pregnancy or breastfeeding.
